KMID : 0361520070180020081
|
|
Korean Journal of Psychopharmacology 2007 Volume.18 No. 2 p.81 ~ p.85
|
|
Assessment of Abdominal Fat and Mid-Thigh Low-Density Muscle Areas in Patients with Schizophrenia
|
|
Kim Chul-Sik
Nam Yoon-Young Park Jong-Suk Kim Hai-Jin Noh Tae-Woong Nam Ji-Sun Ahn Chul-Woo Kim Kyung-Rae Cha Kyung-Ryeol Kim Chan-Hyung
|
|
Abstract
|
|
|
Objective : Patients with schizophrenia are at a higher risk for developing insulin resistance and type 2 diabetes mellitus (T2DM). However, few studies have examined abdominal fat and mid-thigh low-density muscle areas, which are known risk factors for insulin resistance and T2DM, in patients with schizophrenia. Therefore, we measured the abdominal fat and mid-thigh low-density muscle areas of schizophrenics and compared them with normal controls.
Methods£ºNineteen (four men and 15 women) drug-naive or -free subjects who met the DSM IV criteria for schizophrenia and 19 age- and sex-matched controls were recruited. We measured weight, height, waist circumference, and percent body fat, and calculated the body mass index (BMI). Abdominal fat and mid-thigh low-density
muscle areas were evaluated using computed tomography.
Results£ºThere was no significant difference in terms of age and BMI between the two groups. The areas of abdominal fat (262.4¡¾101.8 vs. 257.1¡¾93.8 §²£»p=0.919), subcutaneous fat (182.4¡¾72.8 vs. 180.5¡¾75.1 §²£»p=0.988), visceral fat (79.9¡¾47.2 vs. 76.6¡¾49.3 §²£» p=0.872), and mid-thigh low-density muscle (15.0¡¾9.9 vs. 15.4¡¾5.2 §², p=0.373) did not differ between schizophrenics and controls.
Conclusion£ºAbdominal obesity is a well-recognized risk factor for developing certain medical conditions such as insulin resistance and T2DM. We demonstrated that drug-naive or- free patients with schizophrenia do not have increased visceral fat or mid-thigh low-density muscle areas, which might have explained the higher prevalence of insulin resistance and T2DM in these patients.
|
|
KEYWORD
|
|
Schizophrenia, Abdominal fat, Mid-thigh low-density muscle, Insulin resistance, Type 2 diabetes
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|